National Immunization Awareness Month might be coming to a close, but it’s important to continue helping people understand why vaccines
Category Archives: Uncategorized
Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections
A Tetraphase Pharmaceuticals antibiotic has earned FDA approval, adding a new treatment to the effort to address drug-resistant infections. The
Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise
IQVIA – a nonpartisan health care research firm – is out with troubling new data showing a direct correlation between
FDA Gives Thumbs-Down to Rare Disease Drug from Ionis, Akcea
The FDA has rejected the rare-disease drug volanesorsen (Waylivra), which is being developed by Ionis Pharmaceuticals (NASDAQ: IONS) and its
EuroGEOSS Workshop – 12-14 September 2018, Geneva, Switzerland
[Source: Research & Innovation] The EuroGEOSS Workshop is co-organised by the Swiss Federal Office for the Environment and the European
AbbVie’s Susie Jun Joins Allogene as Chief Development Officer
Allogene has appointed Susie Jun to serve as chief development officer. Jun comes to the cancer immunotherapy developer from AbbVie
EPA Lag in Cellulosic Ethanol Approvals Hurting Rural America
In comments filed to the EPA August 17 on the 2019 proposed volumes for the renewable fuel standard, BIO urged
Call for 4-year Framework Partnership Agreements
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: JUST-NETW-2017Pillar: Justice programme 2014-2020Opening Date: Deadline: Tue, 30 May 2017 17:00:00 (Brussels local time)Modification Date: Fri, 24
Eventbrite Targets $200M IPO as Tech, Biotech Markets Remain Hot
Event tech service Eventbrite is hoping to raise $200 million in an initial public offering during what has already been